USFDA classifies Aurobindo Pharma’s Raleigh plant as VAI
The facility received 11 observations during the USFDA inspection conducted from March 24 to April 10, 2025
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurolife Pharma
WHO alerts unregulated supply of Falsified (contaminated) Oxymorphone Hydrochloride 40mg
Falsified (contaminated) Oxymorphone Hydrochloride 40mg has been identified in the WHO Region for Europe
Aurobindo Pharma subsidiary’s plant gets one observation from US FDA
The plant is owned by Aurolife Pharma, a wholly-owned step down subsidiary of the company
Aurobindo Pharma receives USFDA approval for fenofibrate tablets
The approved ANDA is bioequivalent and therapeutically equivalent to Tricor tablets of AbbVie